|Articles|January 1, 2008
Two-hour MRSA blood test approved
Advertisement
FDA News
On January 2, the Food and Drug Administration (FDA) approved a two-hour staph blood test, which can detect 100% of dangerous specimens and 98% of more commonplace bacteria.
The test, Becton Dickinson's BD GeneOhm StaphSR Assay, is designed to test for methicillin-resistant Staphylococcus aureus (MRSA). Previous tests could take days to deliver results. BD has also submitted paperwork for tests based on nasal swabs and wound claims.
The panel tests for 12 viruses and viral subtypes, including influenza A, human metapneumovirus, and adenovirus. The test is currently available.
Newsletter
Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Steroid Safety, Growth Concerns, and When to Escalate Pediatric Therapy
2
Pediatric respiratory infection patterns shift after COVID-19 pandemic
3
Infant botulism outbreak linked to powdered formula under FDA investigation
4
AbbVie submits FDA, EMA applications for upadacitinib (RINVOQ) in non-segmental vitiligo for 12 years and older
5